메뉴 건너뛰기




Volumn 68, Issue 5, 2012, Pages 877-879

EMA's reflection on placebo does not reflect patients' interests

Author keywords

Clinical research; Drug regulation; Pharmacological research; Placebo; Randomized clinical trials; Three arm trials

Indexed keywords

NEW DRUG; PLACEBO;

EID: 84864290659     PISSN: 00316970     EISSN: 14321041     Source Type: Journal    
DOI: 10.1007/s00228-011-1175-4     Document Type: Note
Times cited : (9)

References (9)
  • 2
    • 36549021534 scopus 로고    scopus 로고
    • Non-inferiority trials are unethical because they disregard patients' interests
    • DOI 10.1016/S0140-6736(07)61604-3, PII S0140673607616043
    • Garattini S, Bertele' V (2007) Non-inferiority trials are unethical because they disregard patients' interests. Lancet 370(9602):1875-1877. doi:10.1016/S0140-6736(07)61604-3 (Pubitemid 350180009)
    • (2007) Lancet , vol.370 , Issue.9602 , pp. 1875-1877
    • Garattini, S.1    Bertele, V.2
  • 3
    • 0004177253 scopus 로고    scopus 로고
    • Accessed 18 July 2011
    • World Medical Association (1964-2008) (2008) The Declaration of Helsinki. Available at: http://www.wma.net/en/30publications/10policies/b3/. Accessed 18 July 2011
    • (2008) The Declaration of Helsinki
  • 4
    • 58049142062 scopus 로고    scopus 로고
    • Final rule 28 April 2008, effective, October 27 2008 Accessed 18 July 2011
    • DHHS Food and Drug Administration. 21 CFR part 312 (2008) Human subject protection; foreign clinical studies not conducted under an investigational new drug application. Final rule 28 April 2008, effective, October 27 2008. Available at: http://www.regulations.gov/fdmspublic/component/main? mainDocumentDetail&o=0900006480537f08. Accessed 18 July 2011
    • (2008) Human Subject Protection; Foreign Clinical Studies Not Conducted Under an Investigational New Drug Application
  • 5
    • 33845765623 scopus 로고    scopus 로고
    • CNS drugs approved by the centralised European procedure: True innovation or dangerous stagnation?
    • DOI 10.1007/s00213-006-0629-3
    • Barbui C, Cipriani A, Lintas C, Bertele' V, Garattini S (2007) CNS drugs approved by the centralised European procedure: true innovation or dangerous stagnation? Psychopharmacology (Berl) 190 (2):265-268. doi:10.1007/s00213-006- 0629-3 (Pubitemid 46011186)
    • (2007) Psychopharmacology , vol.190 , Issue.2 , pp. 265-268
    • Barbui, C.1    Cipriani, A.2    Lintas, C.3    Bertele, V.4    Garattini, S.5
  • 6
    • 0037014947 scopus 로고    scopus 로고
    • Efficacy, safety, and cost of new anticancer drugs
    • Garattini S, Bertele' V (2002) Efficacy, safety, and cost of new anticancer drugs. Br Med J 325(7358):269-271 (Pubitemid 34864399)
    • (2002) British Medical Journal , vol.325 , Issue.7358 , pp. 269-271
    • Garattini, S.1    Bertele, V.2
  • 9
    • 77950920198 scopus 로고    scopus 로고
    • Placebo interventions for all clinical conditions
    • doi:10.1002/14651858.CD003974.pub3
    • Hrobjartsson A, Gotzsche PC (2010) Placebo interventions for all clinical conditions. Cochrane Database Syst Rev (1): CD003974. doi:10.1002/14651858. CD003974.pub3
    • (2010) Cochrane Database Syst Rev , Issue.1
    • Hrobjartsson, A.1    Gotzsche, P.C.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.